LogicBio Therapeutics, Inc. Company Profile

08:51 EDT 19th June 2018 | BioPortfolio

Launched in 2016, LogicBio is a leading genome-editing company founded by pioneers in gene therapy from Stanford University, with a mission to develop transformative medicines for life-threatening diseases. Its GeneRide™ technology enables highly specific genome editing and integration of the therapeutic transgene, utilizing the body's own native processes to drive durable expression. LogicBio is initially targeting a wide range of diseases not addressable today, including early-onset conditions in young patients. With a world-class global team headquartered in Cambridge, Massachusetts, LogicBio is working to deliver the next wave of innovation in genetic medicine.

News Articles [777 Associated News Articles listed on BioPortfolio]

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe medicines with lasting therapeutic benefit for children with life-threatening diseases, today announced it will be prese...

LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer

Genome editing company adds drug development expert in pursuit of breakthrough medicines for pediatric patients LogicBio Therapeutics, Inc., a genetic medicine company ...

LogicBio Therapeutics Announces Expansion of Leadership Team through Multiple Key Hires

LogicBio Therapeutics, Inc., a gene-therapy company with a mission to develop transformative medicines for life-threatening diseases, today announced the expansion of its l...

LogicBio Therapeutics Strengthens Leadership Team with Key Appointments

Sandra Poole named chief operating officer Paul Herzich named senior director of manufacturing LogicBio Therapeutics, Inc., a genetic medicine company founded ...

Management Tracks: Lilly, LogicBio

LogicBio Therapeutics to Present Data on GeneRide™ Platform Technology at 2018 American Society of Gene & Cell Therapy Conference

Efficacy and durability of genome editing platform to be highlighted in presentations by NIH and others LogicBio Therapeutics, Inc., a genetic medicine company founded ...

LogicBio Therapeutics Launches Development Program in Methylmalonic Acidemia (MMA)

Preclinical data demonstrate potential for LB-001 to address the underlying cause of MMA LogicBio Therapeutics, Inc., a genetic medicine company founded to develop ...

What You Need to Know About Indalo Therapeutics

Indalo Therapeutics is based in St. Louis and was formed in October 2016 from the merger of Antegrin Therapeutics and Cascadia Therapeutics.

PubMed Articles [411 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Eyes on New Product Development: Preclinical Research.

Eyes on New Product Development: Preclinical Research.

Clinical Trials [144 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1237 Associated Companies listed on BioPortfolio]

LogicBio Therapeutics, Inc.

Launched in 2016, LogicBio is a leading genome-editing company founded by pioneers in gene therapy from Stanford University, with a mission to develop transformative medicines for...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...

More Information about "LogicBio Therapeutics, Inc." on BioPortfolio

We have published hundreds of LogicBio Therapeutics, Inc. news stories on BioPortfolio along with dozens of LogicBio Therapeutics, Inc. Clinical Trials and PubMed Articles about LogicBio Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LogicBio Therapeutics, Inc. Companies in our database. You can also find out about relevant LogicBio Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record